Healthcare • Biotechnology
EODHD (TTM) · as of Oct 13, 2026
End-of-day close from stored market data, not a live quote.
Sign in to see your position size
We’ll show you if VSTM is in your portfolio and how much it contributes.
Sign inLoading market dates
No upcoming ex-dividend date announced
No 8-K filings in the last 30 days.
32 top institutions tracked
Last 13F trend: accumulating (light)
Unlock crowding heatmapUnlock filer discoverySentiment: bearish
Last trade: sell 12 days ago
Red flags: 2
158 filers reported a long position in VSTM for Q2 2026. 13-F holdings are filed up to 45 days after the quarter ends.
| Holder | Value | Shares | Shares vs Q1 2026 |
|---|---|---|---|
| BlackRock, Inc. | $35.1M | 9.2M | +48.4% |
| ARMISTICE CAPITAL, LLC | $26.8M | 7M | +53% |
| RTW INVESTMENTS, LP | $25.3M | 6.6M | +0.9% |
| Deep Track Capital, LP | $21.9M | 5.7M | Unchanged |
| STATE STREET CORP | $19.6M | 5.1M | +46% |
| Rosalind Advisors, Inc. | $15.2M | 4M | +86.4% |
| VANGUARD CAPITAL MANAGEMENT LLC | $14.7M | 3.9M | +15.9% |
| Nantahala Capital Management, LLC | $13.7M | 3.6M | Unchanged |
| Stonepine Capital Management, LLC | $12.8M | 3.3M | +1.4% |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $12.5M | 3.3M | +331.6% |
Unlock detailed insider transactions, institutional holder changes, factor exposures, and personalized alerts. Start free with your own portfolio.